RecruitingNot ApplicableNCT05185219

The Effect of Valerian on Insomnia in Menopausal Women

The Effect of Valerian on Insomnia in Menopausal Women: Randomized Placebo-controlled Trial


Sponsor

China Medical University Hospital

Enrollment

100 participants

Start Date

Dec 14, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Menopausal women often complain that it is difficult to fall asleep and easy to wake up at night and early in the morning and it is in the middle of night difficult to fall asleep again. If the above symptoms persist for at least three months and occur at least three times a week, plus the impact on daytime work and rest, and meet the International Classification of Sleep Disorders (ICSD-3) )'S s "Insomnia" diagnostic criteria. According to statistics, 30% to 60% of women face sleep disorders during menopause.


Eligibility

Sex: FEMALEMin Age: 45 YearsMax Age: 60 Years

Inclusion Criteria3

  • 〜60 years old, and is menopaused for at least 1 year。
  • meet the criteria of ICSD-3 for insomnia
  • PSQI \> 5

Exclusion Criteria5

  • psychiatry disease
  • Heart, brain, liver diseases
  • Insomnia is caused by diseases.
  • Steroid used within 6 months
  • pregnant or breastfeeding

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGValerian

A natural plant


Locations(1)

China Medical University

Taichung, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05185219


Related Trials